Browse > Article

Comparative of the Nutritional Status and Correlation of Cardiovascular Disease in Type Ⅱ Diabetes Mellitus Patients with Metabolic Syndromes  

Lim, Hee-Sook (Department of Nutrition team, Soonchunhyang University Bucheon Hospital)
Kim, Soon-Kyung (Department of Food sciences & Nutrition, Soonchunhyang University)
Publication Information
Journal of Nutrition and Health / v.41, no.4, 2008 , pp. 327-340 More about this Journal
Abstract
This study was designed to investigate the correlation between nutrition status and cardiovascular disease in type 2 diabetes patients with metabolic syndrome. The subjects were 66 patients and divided into Non MS (a group without metabolic syndrome, n = 37) and MS (a group with metabolic syndrome, n = 29). The percentage of patients accompanying metabolic syndrome was 43.9% and family history such as DM, skipping meal and eating speed were higher in MS (P < 0.05) The average values of BMI, body fat (%), waist circumference were significantly higher in patients of MS than that of Non MS. For hamatological values, MS showed higher FRS, HOMA-IR, LDL-Cholesterol, CRP. Percentage of FRS was 21.63% in MS that is relatively higher in comparison with 16.81% in Non MS. Moreover, the incidence of cardiovascular disease appeared 13.8% in MS that is higher than 2.7% in Non MS. The intake of sodium and vitamin E were higher, but the intake of fat, vitamin A and zinc were lower in MS than in Non MS. Close correlations were elucidated among FRS, occurrence of cardiovascular disease, weight, waist circumference, Total-Cholesterol, LDLCholesterol, sodium in both groups. In conclusion, cardiovascular disease risk factors would be higher in type 2 diabetes patients with metabolic syndrome and there were distinctive patterns that were associated with hamatological values, nutrition intake risk factors. This result should be considered when designing nutrition study and intervetion programs.
Keywords
nutritional status; occurrence of cardiovascular disease; type II diabetes mellitus; metabolic syndrome;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 2001 American Diabetes Association. Global prevalence of diabetes. Diabetes Care 2004; 27(2): 1047-1053   DOI   ScienceOn
2 National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in Adult Treatment Panel III (ATP III): final report. Circilation 2001; 106: 2085-2090
3 The Korean Nutrition Society. Dietary Reference Intakes for Koreans. Seoul; 2005
4 Kim NK. Internal Medicine. Korea; 1998. p.189
5 Lee MS. Relationshop of the relative risks of the metabolic syndrome and dietary habits of middle-aged in seoul. Korean J Community Nutrition 2004; 9(6): 695-705
6 Lee SH, Choi SH, Kim HJ, Chung YS. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. J Korean Med Sci 2006; 21(4): 695-700   DOI   ScienceOn
7 Park YM, Sohn JM, Jang HC. Correlation of carbohydrate intake with obesity in type 2 diabetes mellitus patients. J Korean Dietetic Assoc 2006; 12(3): 254-263
8 Korean Diabetes Association. Available from: http://www.diabetes. or.kr
9 Nicola MM, James BM, Simin L. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clinical Nutrition 2002; 76(8): 390-398   DOI
10 Lee YJ, Kim SM. The Association of Hair Zinc with Metabolic Risk Factors for Selected Women in Korea. Journal of Korean Oriental Association for Study of Obesity 2005; 14(3): 170-178
11 Shok JH, Kim Y, Lee SH, Hong KR, Park JS. Correlations of creactive protein levels and framingham coronary risk score. Korean J Med 2007; 73(3): 283-290
12 Ford ES, Mokdad AH, Glies WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003; 52(9): 2346-2352   DOI   ScienceOn
13 Ahmad E, Masoud K, Yadollah M. Fruit and vegetable intake, creactive protein, and the metabolic syndrome. Am J Clin Nutr 2006; 84: 1489-1497   DOI
14 S. Goya Wamametee, Gerald Shaper, Lucy Lennon, Richard W. Morris. Metabolic syndrome vs framingham risk score for prediction of coronary heart disease, stroke and type 2 diabetes mellitus. J Am Med Assoc 2007; 13: 2644-2650
15 Joung IK. Clinical significance and treatment principle of metabolic syndrome. Diabetes 2006; 7(3): 25-31
16 Ascaso JF, Pardo S, Real JT. Diagnostic insulin resistance by simple quantitive mathods in subjects with normal glucose matebolism. Diabetes Care 2003; 26(2): 3320-3325   DOI   ScienceOn
17 Kim NK. Internal Medicine. Korea; 1998. p.716
18 Korean Society of Lipidology and Atheroscleosis. Incidence of cardiovascular disease. Available from: http://lipid.or.kr/g_heart
19 Chambers JC, Eda S, Bassett P. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indians from the United Kingdom compared with European Whites. Circulation 2001; 104: 145-150   DOI
20 Maarit H, Leena T, Hannu M, Jyrki A. Interaction between cholesterol and glucose metabolism during dietary carbohydrate modification in subjects with the metabolic syndrome. Am J Clin Nutr 2006; 84: 1385-1392   DOI
21 Kim JH, Kwon HS, Park YM. Best surrogate marker for insulin resistance in middle-aged non-diabetic Korean. Korean J Med 2007; 73(6): 611-617
22 Yoshimasa A, Sadao W. High serum high-sensitivity c-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetes patients with metabolic syndrome. Metabolism 2006; 55: 1014-1021   DOI   ScienceOn
23 Lamarche B, Tchernof A, Moorjani S, Despress JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997; 95: 69-75   DOI
24 Shin YS, Kim OY, Lee HK. Risk factors for non-insulin dependent diabetes mellitus. J Korean Diabetes Assoc 2006; 20(1): 14-24
25 Isomma B, Almgren P, Tuomi T, Forsen B. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24(4): 683-689   DOI   ScienceOn
26 Choi JE, Seo JS. Interrelationship between diabetic control and related factors of dietary compliance in diabetic patients. J Korean Dietetic Assoc 2005; 111(2): 137-146
27 Rodriguez MM, Guerrero RF. Increased levels of c-reactive protein in non-controlled type II diabetic subjects. J Diabetes Complications 1999; 13: 211-215   DOI   ScienceOn
28 Obeid O, Elfakhani M, Hlais S, Iskandar M, Batal M. Plasma copper, zinc, and selenium levels and correlates with metabolic syndrome components of lebanese Adults. Biol Trace Elem Res 2008; 21(1): 196-210
29 Reinhard W, Holmer SR, Fischer M. Association of the metabolic syndrome with early coronary disease in families with frequent myocardial infarction. Am J Cardiol 2006; 97: 964-967   DOI   ScienceOn
30 Won JC, Park JY, Song KH, Lee WJ. Changes in the prevalence of metabolic syndrome in a rural area of korea defined by two criteria, revised National Cholesterol Education Program and International Diabetes Federation. Diabetes 2007; 31(3): 284-292   DOI
31 Kim MH, Lee HS, Park HJ, Kim WY. Risk factors associated with metabolic syndrome in Korean elderly. Ann Nutr Metab 2007; 51(6): 533-540   DOI   ScienceOn
32 Son GP, Choi YJ, Lee TU, Joung IK. The influence of metabolic syndrome on the intima-medial thickness and cardiovascular risk factors in type 2 diabetes. Diabetes 2004; 28(4): 392-406
33 American Heart Association. Scientific Statements and Practice Guidelines for 2007-2008. Available from: http://www.american heart.org/presenter.jhtml?identifier=9181
34 Lakka HM, Laaksonen DE, Lakka TA. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288(4): 2709-2716   DOI   ScienceOn
35 Ginsberg HN. The metabolic syndrome: targeting dyslipidemia to reduce coronary risk. J Cardiovasc Risk 2003; 10(2): 121-128   DOI   ScienceOn
36 Cha BS. Dianosis of metabolic syndrome. Diabetes 2006; 7(1): 20-24
37 Kim NK. Internal Medicine. Korea; 1998. p.193
38 Walldius G, Junger I, Holme I. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001; 358: 2026-2033   DOI   ScienceOn
39 Kim SK, Kim DR, Shin DH, Kim NH. The association between CRP and the metabolic syndrome in Korean adults. Korean Endocrinal 2002; 17(2): 226-235
40 Ministry for Health, Welfare and Family Affairs. Korea health and nutrition survey. 2005. Available from:http://knhanes.cdc.go.kr/ result/Result_03.aspx
41 Psaty BM, Lumley T, Furberg CD. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29(1): 177-188
42 Aguilar MV, Saavedra P, Arrieta FJ, Mateos CJ. Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab 2007; 51(5): 402-406   DOI   ScienceOn
43 Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease. J Gen Intern Med 2003; 18(12): 1039-1052   DOI   ScienceOn
44 Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian Men. J Clin Endocrinol Metab 2004; 89(6): 2750-2755   DOI   ScienceOn
45 Hwang ST, Sung KC, Kim BJ. Insulin resistance and apolipoprotein B as a metabolic syndrome risk factor in normal glucose tolerance. Korean J Med 2004; 66(2): 156-166
46 Liese AD, Mayer-Davis EJ, Tyroler HA. Familial components of the multiple metabolic syndrome: the ARIC study. Diabetologia 1996; 40: 936-970
47 Ataru T, Shoichiro N, Mitsuo F. C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 2002; 51(12): 1578-1581   DOI   ScienceOn
48 Park YM, Sohn CM, Jang HC. Correlation of carbohydrate intake with obesity in type 2 diabetes mellitus patients. J Korean Dietetic Assoc 2006; 12(2): 254-263
49 National Institutes of Health. The Third report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in Adult. Available from: http://www.nhlbi.nih.gov/guidelines/ cholesterol/risk_tbl.htm